Skip to main content
MXCT
NASDAQ Life Sciences

Q3 Revenue Jumps 49% to $10.2M, Full-Year Guidance Raised to at Least $34.5M

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.43
Mkt Cap
$134.168M
52W Low
$0.643
52W High
$1.805
52W Position info
122% above low
Off High info
21% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

MXCT has more than doubled off its 52-week low of $0.643.

Summary

MaxCyte posted Q3 2026 total revenue of $10.2 million, up 49% from a year ago, with core revenue of $8.2 million up 27% and SPL program revenue of $2.0 million versus $0.4 million. The net loss narrowed to $4.8 million from $12.4 million as operating expenses fell to $14.5 million from $19.4 million. Management raised full-year 2026 total revenue guidance to at least $34.5 million, implying a return to full-year growth, split between roughly $28 million core and at least $6.5 million SPL, and expects roughly 15% core growth in the second half. The company held $132.7 million in cash and investments at quarter-end, though it expects $40-45 million by year-end after paying about $105 million in cash for Akron Bio plus deal costs, with $22 million drawn on the MidCap facility. The Akron acquisition announced this morning is the bigger story; these results show the standalone business accelerating into the deal.

At the time of this announcement, MXCT was trading at $1.43 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $134.2M. The 52-week trading range was $0.64 to $1.81. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

MXCT - Latest Insights

MXCT
Nov 10, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1.23
Real-time Price: $1.41 info
Change: +$0.1796 (+15%) info
Market Cap: $134.168M info
MXCT
Oct 14, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.00
Real-time Price: $1.41 info
Change: +$0.410 (+41%) info
Market Cap: $134.168M info
MXCT
Aug 04, 2026, 8:42 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $1.06
Real-time Price: $1.41 info
Change: +$0.350 (+33%) info
Market Cap: $134.168M info
MXCT
Jul 21, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.21
Real-time Price: $1.41 info
Change: +$0.1956 (+16%) info
Market Cap: $134.168M info
MXCT
Jun 16, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $1.14
Real-time Price: $1.41 info
Change: +$0.270 (+24%) info
Market Cap: $134.168M info